Sun Pharmaceutical Industries (NSE:SUNPHARMA, BOM:524715) said CRISIL removed the Rating Watch with Developing Implications status and reaffirmed the rating assigned to its long-term bank facilities at CRISIL AAA.
The outlook is stable, according to a Wednesday Indian bourse filing.